India has emerged as a global hub for pharmaceutical manufacturing, established for its robust production capabilities and cost-effective pricing. The industry is characterized by a broad range of players, from small indigenous firms to contract research and manufacturing organizations (CROs). Regulatory bodies initiatives have significantly contri